Modified STRONGkids outperforms PYMS for WHO-defined malnutrition: a screening-to-action pathway for pediatric wards

Hong Chen1, Yu Zhang1, Hongwei Han1

  • 1Department of Pediatrics, Wenzhou People's Hospital, Wenzhou, Zhejiang, China.

PubMed

Insights

Hospitalized children with digestive diseases and infants under one year old face higher malnutrition risks. The modified STRONGkids tool is more effective than PYMS for identifying at-risk children.

Area of Science:

  • Pediatric Nutrition
  • Clinical Assessment
  • Malnutrition Screening

Background:

  • Nutritional status is crucial for hospitalized children's outcomes.
  • Early identification of malnutrition risk is essential for timely intervention.
  • Existing screening tools require evaluation for clinical utility.

Purpose of the Study:

  • To assess the nutritional status of hospitalized children.
  • To evaluate the clinical application of modified STRONGkids and PYMS screening tools.
  • To compare the effectiveness of these tools in identifying malnutrition risk.

Main Methods:

  • Nutritional risk screening of 302 hospitalized children using modified STRONGkids and PYMS tools.
  • Analysis of clinical outcomes and biochemical indicators based on nutritional status.
  • Comparison of screening tool performance (sensitivity, accuracy).

Main Results:

  • Nearly 50% of children were identified as borderline malnourished or malnourished.
  • Digestive system diseases and age under 1 year were associated with significantly higher malnutrition risk.
  • Modified STRONGkids showed higher sensitivity and accuracy than PYMS in identifying malnutrition risk.

Conclusions:

  • Children with digestive diseases and infants are a high-risk group for malnutrition.
  • Both modified STRONGkids and PYMS effectively identify at-risk children.
  • The modified STRONGkids tool demonstrates superior clinical application for malnutrition screening in pediatric inpatients.
Abstract

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...